Anti-EFR3A monoclonal antibody
Anti-EFR3A antibody for FACS & in-vivo assay
Go to EFR3A/EFR3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP2094-Ab-1/ GM-Tg-hg-MP2094-Ab-2 | Anti-Human EFR3A monoclonal antibody | Human |
GM-Tg-rg-MP2094-Ab-1/ GM-Tg-rg-MP2094-Ab-2 | Anti-Rat EFR3A monoclonal antibody | Rat |
GM-Tg-mg-MP2094-Ab-1/ GM-Tg-mg-MP2094-Ab-2 | Anti-Mouse EFR3A monoclonal antibody | Mouse |
GM-Tg-cynog-MP2094-Ab-1/ GM-Tg-cynog-MP2094-Ab-2 | Anti-Cynomolgus/ Rhesus macaque EFR3A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP2094-Ab-1/ GM-Tg-felg-MP2094-Ab-2 | Anti-Feline EFR3A monoclonal antibody | Feline |
GM-Tg-cang-MP2094-Ab-1/ GM-Tg-cang-MP2094-Ab-2 | Anti-Canine EFR3A monoclonal antibody | Canine |
GM-Tg-bovg-MP2094-Ab-1/ GM-Tg-bovg-MP2094-Ab-2 | Anti-Bovine EFR3A monoclonal antibody | Bovine |
GM-Tg-equg-MP2094-Ab-1/ GM-Tg-equg-MP2094-Ab-2 | Anti-Equine EFR3A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP2094-Ab-1/ GM-Tg-hg-MP2094-Ab-2; GM-Tg-rg-MP2094-Ab-1/ GM-Tg-rg-MP2094-Ab-2; GM-Tg-mg-MP2094-Ab-1/ GM-Tg-mg-MP2094-Ab-2; GM-Tg-cynog-MP2094-Ab-1/ GM-Tg-cynog-MP2094-Ab-2; GM-Tg-felg-MP2094-Ab-1/ GM-Tg-felg-MP2094-Ab-2; GM-Tg-cang-MP2094-Ab-1/ GM-Tg-cang-MP2094-Ab-2; GM-Tg-bovg-MP2094-Ab-1/ GM-Tg-bovg-MP2094-Ab-2; GM-Tg-equg-MP2094-Ab-1/ GM-Tg-equg-MP2094-Ab-2 |
Products Name | Anti-EFR3A monoclonal antibody |
Format | mab |
Target Name | EFR3A |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-EFR3A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species EFR3A VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm003121 | mouse Efr3a Lentivirus plasmid |
ORF Viral Vector | vGMLPm003121 | mouse Efr3a Lentivirus particle |
Target information
Target ID | GM-MP2094 |
Target Name | EFR3A |
Gene ID | 23167,76740,362923,696036,475102,101092992,535125,100057838 |
Gene Symbol and Synonyms | A130089M23Rik,C920006C10Rik,D030063F01Rik,EFR3A,mKIAA0143,RGD1305976 |
Uniprot Accession | Q14156 |
Uniprot Entry Name | EFR3A_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Ovary Cancer |
Gene Ensembl | ENSG00000132294 |
Target Classification | N/A |
The target: EFR3A, gene name: EFR3A, also named as . The protein encoded by this gene is part of a complex that plays a role in maintaining an active pool of phosphatidylinositol 4-kinase (PI4K) at the plasma membrane. This protein is thought to be a peripheral membrane protein that associates with the plasma membrane through palmitoylation. Studies indicate that this gene product plays a role in controlling G protein-coupled receptor (GPCR) activity by affecting receptor phosphorylation. Whole exome sequencing studies have implicated mutations in this gene with autism spectrum disorders. [provided by RefSeq, Apr 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.